NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Capital Work in Progress | ₹137 Cr | ₹64 Cr | ₹130 Cr | ₹223 Cr | ₹518 Cr |
What is the latest Capital Work in Progress ratio of NATCO PHARMA ?
Year | Capital Work in Progress |
---|---|
Mar2024 | ₹137 Cr |
Mar2023 | ₹64 Cr |
Mar2022 | ₹130 Cr |
Mar2021 | ₹223 Cr |
Mar2020 | ₹518 Cr |
How is Capital Work in Progress of NATCO PHARMA Trending?
Years | Capital Work in Progress | % Change | |
---|---|---|---|
Mar2024 | ₹137 Cr | 113.53 | |
Mar2023 | ₹64 Cr | -50.35 | |
Mar2022 | ₹130 Cr | -42.03 | |
Mar2021 | ₹223 Cr | -56.87 | |
Mar2020 | ₹518 Cr | - |
Compare Capital Work in Progress of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹15,070.4 Cr | -5.4% | 2.3% | -17.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,778.0 Cr | 2.3% | 5.6% | 21.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,949.0 Cr | 1.5% | 4.2% | 51.2% | Stock Analytics | |
CIPLA | ₹123,222.0 Cr | 0% | 2.9% | 10% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,205.0 Cr | 0.6% | 0.9% | 23.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,707.7 Cr | 0.8% | 1.8% | -5.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -5.4% |
2.3% |
-17.5% |
SENSEX | 0.9% |
4.2% |
8.3% |
You may also like the below Video Courses